Lgt Group Foundation Abiomed Inc Transaction History

Lgt Group Foundation

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 19, 2022	BUY	$242.49 - $301.46 $722,377 - $898,049	2,979 Added 6.48%	48,979 $12 Million
Q2 2022 Aug 03, 2022	SELL	$224.73 - $338.64 $2.17 Million - $3.27 Million	-9,670 Reduced 17.37%	46,000 $11.4 Million
Q1 2022 May 11, 2022	BUY	$277.25 - $366.29 $5.31 Million - $7.02 Million	19,168 Added 52.51%	55,670 $18.9 Million
Q4 2021 May 03, 2022	BUY	$300.63 - $371.35 $11 Million - $13.6 Million	36,502 New	36,502 $13.1 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Lgt Group Foundation, based on Form 13F filings with the SEC.

Stay updated on Lgt Group Foundation with notifications on news.